We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pieris Pharmaceuticals Inc | NASDAQ:PIRS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.08 | 4.44 | 12.00 | 0 | 09:05:29 |
CUSIP No.
720795103
|
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Advisors LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
2,455,900*
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
2,455,900*
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,455,900*
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.55%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
IA
|
CUSIP No.
720795103
|
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Capital GP III LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
o
(b)
o
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
AF
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
2,437,101*
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
2,437,101*
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,437,101*
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.51%*
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
Item 1.
|
Security and Issuer
|
Item 2.
|
Identity and Background
|
(i)
|
name;
|
|
(ii)
|
business address;
|
(iii)
|
present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted;
|
|
(iv)
|
citizenship.
|
Item 3.
|
Source and Amount of Funds or Other Consideration
|
Item 4.
|
Purpose of Transaction
|
Item 5.
|
Interest in Securities of the Issuer
|
Seller
|
Date of Transaction
|
Transaction
|
Number of Shares
|
Price Per Share*
|
OPI III
|
July 7, 2018
|
Sold
|
261,400
|
$5.32
|
Associates III
|
July 7, 2018
|
Sold
|
2,700
|
$5.32
|
OPI III
|
September 18, 2018
|
Sold
|
168,200
|
$5.30
|
Associates III
|
September 18, 2018
|
Sold
|
1,800
|
$5.30
|
OPI III
|
September 25, 2018
|
Sold
|
248,086
|
$5.79
|
Associates III
|
September 25, 2018
|
Sold
|
1,914
|
$5.79
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer
|
Item 7.
|
Materials to Be Filed as Exhibits
|
|
OrbiMed Advisors LLC
|
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
||
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
OrbiMed Capital GP III LLC
|
|
||
|
|
|
|
|
|
By:
|
OrbiMed Advisors LLC
its Managing Member
|
||
|
By:
|
/s/ Jonathan T. Silverstein
|
||
|
Name:
|
Jonathan T. Silverstein
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
By:
|
/s/ Sven H. Borho
|
||
|
Name:
|
Sven H. Borho
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
|
|
|
|
|
|
By:
|
/s/ Carl L. Gordon
|
||
|
Name:
|
Carl L. Gordon
|
||
|
Title:
|
Member of OrbiMed Advisors LLC
|
||
Name
|
Position with Reporting
Person
|
Principal Occupation
|
Carl L. Gordon
|
Member
|
Member
OrbiMed Advisors LLC
|
Sven H. Borho
German and Swedish Citizen
|
Member
|
Member
OrbiMed Advisors LLC
|
Jonathan T. Silverstein
|
Member
|
Member
OrbiMed Advisors LLC
|
W. Carter Neild
|
Member
|
Member
OrbiMed Advisors LLC
|
Geoffrey C. Hsu
|
Member
|
Member
OrbiMed Advisors LLC
|
Evan D. Sotiriou
|
Chief Financial Officer
|
Chief Financial Officer
OrbiMed Advisors LLC
|
1 Year Pieris Pharmaceuticals Chart |
1 Month Pieris Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions